18.737 makale bulundu

Parkinson hastalığında tedavinin motor kortikal uyarılabilirliğe etkisi.

Effect of therapy on motor cortical excitability in Parkinson's disease.

Soysal A, Sobe I, Atay T, Sen A, Arpaci B.

Can J Neurol Sci · 2008-05-01

DOI: 10.1017/s0317167100008581PMID: 18574929

Parkinson hastalığının klinik motor ve motor olmayan testlerinin tanısal performansı: eşleştirilmiş bir vaka kontrol çalışması.

Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study.

Bohnen NI, Studenski SA, Constantine GM, Moore RY.

Eur J Neurol · 2008-04-24

DOI: 10.1111/j.1468-1331.2008.02148.xPMID: 18435767

NR2A ve NR2B alt birimi seçici NMDA reseptör antagonistlerinin striato-pallidal nöronlar üzerindeki ayırıcı etkisi: parkinsonizm 6-hidroksidopamin modelinde motor tepki ile ilişkisi.

Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.

Fantin M, Auberson YP, Morari M.

J Neurochem · 2008-04-24

DOI: 10.1111/j.1471-4159.2008.05439.xPMID: 18435828

Gama aktivitesinin hareketle ilişkili senkronizasyonu distoni olan hastalarda lateralize edilir.

Movement-related synchronization of gamma activity is lateralized in patients with dystonia.

Brücke C, Kempf F, Kupsch A, Schneider GH, Krauss JK, Aziz T, Yarrow K, Pogosyan A, Brown P, Kühn AA.

Eur J Neurosci · 2008-04-22

DOI: 10.1111/j.1460-9568.2008.06203.xPMID: 18430031

Doğalcı şizofreni popülasyonunda nöroleptik kaynaklı hareket bozuklukları: aktometrik hareket kalıplarının tanısal değeri.

Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.

Janno S, Holi MM, Tuisku K, Wahlbeck K.

BMC Neurol · 2008-04-18

DOI: 10.1186/1471-2377-8-10PMID: 18419829

Kardiyak sempatik denervasyon Parkinson orta çizgi motor semptomları ile ilişkilidir.

Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms.

Kim JS, Lee KS, Song IU, Kim YI, Kim SH, You IR, Kim HT.

J Neurol Sci · 2008-04-18

DOI: 10.1016/j.jns.2008.02.017PMID: 18378259

Parkinson hastalığında visuo-motor adaptasyonunun öğrenilmesi ve konsolidasyonu.

Learning and consolidation of visuo-motor adaptation in Parkinson's disease.

Marinelli L, Crupi D, Di Rocco A, Bove M, Eidelberg D, Abbruzzese G, Ghilardi MF.

Parkinsonism Relat Disord · 2008-04-18

DOI: 10.1016/j.parkreldis.2008.02.012PMID: 18424221

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3.5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN PARKINSON'UN HASTALIKLARINA İLGİLİ ARAŞTIRMASI İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OKSIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE'NİN MOTOR Dİ ⁇ ERLERİNİN PARKINSON'UN HASTALIKLARINA İLGİLİ ÇÖZÜMÜ İÇİN KULLANIMI

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXSIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE

DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES, RAVINET-TRILLOU CHRISTINE.

· 2008-04-16

Ventral mesopontin kavşağındaki nörotoksik lezyonlar uyku sırasında uyku süresini ve kas aktivitesini değiştirir: uykudaki motor bozuklukların hayvan modeli.

Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.

Lai YY, Hsieh KC, Nguyen D, Peever J, Siegel JM.

Neuroscience · 2008-04-16

DOI: 10.1016/j.neuroscience.2008.03.085PMID: 18487021